Environmental Substances Associated with Alzheimer’s Disease—A Scoping Review
Abstract
:1. Introduction
2. Materials and Methods
3. Introduction of the Chemicals
3.1. Pesticides
3.2. Cadmium
3.3. Arsenic
3.4. Lead
3.5. Mercury
4. Results
4.1. Pesticides
4.2. Cadmium
4.3. Arsenic
4.4. Lead
4.5. Mercury
5. Discussion
6. Conclusions
- According to this scoping review, the strongest evidence was detected for pesticides regarding the risk of AD.
- Exposure to mercury is possibly associated with AD development, but results are inconsistent. Though results on cadmium and arsenic and AD are conflicting, they are possibly associated with the risk of disease. The evidence regarding lead is less strong, but also lead can contribute to cognitive decline and the risk of AD.
- The studies selected were often connected to occupational settings, and thus far, many of the chemical exposure studies have been conducted in relation to high exposure occupations.
- Exposure to pesticides, mercury, cadmium, arsenic, and lead may adversely affect cognitive abilities and contribute to the risk of AD. Further, high-quality epidemiological research is needed to confirm the findings.
- Because adverse environmental chemical exposures affect both workers in certain occupations and general public, protecting humans from chemical hazards is an essential public health issue.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Alzheimer’s Disease International (ADI). Dementia Facts & Figures; ADI: London, UK, 2021; Available online: https://www.alzint.org/about/dementia-facts-figures/ (accessed on 20 April 2021).
- World Health Organization (WHO). Factsheet Dementia; WHO: Geneva, Switzerland, 2020; Available online: https://www.who.int/news-room/fact-sheets/detail/dementia (accessed on 20 April 2021).
- Prince, M.; Wimo, A.; Guerchet, M.; Ali, G.-C.; Wu, Y.-T.; Prina, M. World Alzheimer Report 2015: The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends; Alzheimer’s Disease International (ADI): London, UK, 2015. [Google Scholar]
- Lane, C.A.; Hardy, J.; Schott, J.M. Alzheimer’s disease. Eur. J. Neurol. 2018, 25, 59–70. [Google Scholar] [CrossRef] [PubMed]
- Prince, M.; Albanese, E.; Guerchet, M.; Prina, M. World Alzheimer Report 2014: Dementia and Risk Reduction. An Analysis of Protective and Modifiable Factors; Alzheimer’s Disease International (ADI): London, UK, 2014. [Google Scholar]
- Bateman, R.J.; Aisen, P.S.; De Strooper, B.; Fox, N.C.; Lemere, C.A.; Ringman, J.M.; Salloway, S.; Sperling, R.A.; Windisch, M.; Xiong, C. Autosomal-dominant Alzheimer’s disease: A review and proposal for the prevention of Alzheimer’s disease. Alzheimers Res. Ther. 2011, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barber, R.C. The genetics of Alzheimer’s disease. Scientifica 2012, 2012, 246210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brookmeyer, R.; Johnson, E.; Ziegler-Graham, K.; Arrighi, H.M. Focecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007, 3, 186–191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neumann, P.J.; Araki, S.S.; Arcelus, A.; Longo, A.; Papadopoulos, G.; Kosik, K.S.; Kuntz, K.M.; Bhattacharjya, A. Measuring Alzheimer’s disease progression with transition probabilities, Estimates from CERAD. Neurology 2001, 57, 957–964. [Google Scholar] [CrossRef]
- HBM4EU. HBM4EU Priority Substances; HBM4EU: 2020. Available online: https://www.hbm4eu.eu/the-substances/ (accessed on 21 April 2021).
- HBM4EU. About HBM4EU; HBM4EU: 2021. Available online: https://www.hbm4eu.eu/about-hbm4eu/ (accessed on 30 August 2021).
- Ganzleben, C.; Antignac, J.-P.; Barouki, R.; Castaño, A.; Fiddicke, U.; Klánová, J.; Lebret, E.; Olea, N.; Sarigiannis, D.; Schoeters, G.R.; et al. Human biomonitoring as a tool to support chemicals regulation in the European Union. Int. J. Hyg. Environ. Health 2017, 220, 94–97. [Google Scholar] [CrossRef] [PubMed]
- Ormsby, J.-N.; Lecoq, P.; Ougier, E.; Rousselle, C.; Ganzleben, C.; Prioritisation Strategy and Criteria. HBM4EU Deliverable Report D 4.3. HBM4EU 2017. Available online: https://www.hbm4eu.eu/wp-content/uploads/2017/03/HBM4EU_D4.3_Prioritisation_strategy_criteria-1.pdf (accessed on 26 April 2021).
- Sucharew, H.; Macaluso, M. Methods for research evidence synthesis: The scoping review approach. J. Hosp. Med. 2019, 14, 416–418. [Google Scholar] [CrossRef] [Green Version]
- Munn, Z.; Peters, M.D.J.; Stern, C.; Tufanaru, C.; McArthur, A.; Aromataris, E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol. 2018, 18, 143. [Google Scholar] [CrossRef] [PubMed]
- Levac, D.; Colquhoun, H.; O’Brien, K.K. Scoping studies: Advancing the methodology. Implement. Sci. 2010, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nordberg, G.F.; Nogawa, K.; Nordberg, M. Cadmium. In Handbook on the Toxicology of Metals, 4th ed.; Nordberg, G., Fowler, B.A., Nordberg, M., Eds.; Elsevier: London, UK, 2014; Volume 1, pp. 667–716. ISBN 978-0-12-398292-6. [Google Scholar]
- Esteban, M.; Castaño, A. Non-invasive matrices in human biomonitoring: A review. Environ. Int. 2009, 35, 438–449. [Google Scholar] [CrossRef]
- Apel, P.; Angerer, J.; Wilhelm, M.; Kolossa-Gehring, M. New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission. Int. J. Hyg. Environ. Health 2017, 220, 152–166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barbosa, F., Jr.; Tanus-Santos, J.E.; Gerlach, R.F.; Parsons, P.J. A critical review of biomarkers used for monitoring human exposure to lead: Advantages, limitations, and future needs. Environ. Health Perspect. 2005, 113, 1669–1674. [Google Scholar] [CrossRef] [Green Version]
- Wilhelm, M.; Heinzow, B.; Angerer, J.; Schulz, C. Reassessment of critical lead effects by the German Human Biomonitoring Commission results in suspension of the human biomonitoring values (HBM I and HBM II) for lead in blood of children and adults. Int. J. Hyg. Environ. Health 2010, 213, 265–269. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). Chemical Safety: Pesticides; WHO: Geneva, Switzerland, 2020; Available online: https://www.who.int/news-room/q-a-detail/chemical-safety-pesticides (accessed on 28 April 2021).
- World Health Organization (WHO). Pesticide Residues in Food; WHO: Geneva, Switzerland, 2018; Available online: https://www.who.int/news-room/fact-sheets/detail/pesticide-residues-in-food (accessed on 28 April 2021).
- Bjørling-Poulsen, M.; Andersen, H.R.; Grandjean, P. Potential developmental neurotoxicity of pesticides used in Europe. Environ. Health 2008, 7, 50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaur, R.; Mavi, G.K.; Raghav, S.; Khan, I. Pesticides classification and its impact on environment. Int. J. Curr. Microbiol. App. Sci. 2019, 8, 1889–1897. [Google Scholar] [CrossRef]
- Nordberg, G.F.; Bernard, A.; Diamond, G.L.; Duffus, J.H.; Illing, P.; Nordberg, M.; Bergdal, I.A.; Jin, T.; Skerfving, S. Risk assessment of effects of cadmium on human health (IUPAC Technical Report). Pure Appl. Chem. 2018, 90, 755–808. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization (WHO). Health Risks of Heavy Metals from Long-Range Transboundary Air Pollution; WHO: Geneva, Switzerland, 2007; Available online: http://www.euro.who.int/__data/assets/pdf_file/0007/78649/E91044.pdf (accessed on 28 April 2021).
- World Health Organization (WHO). Lead Poisoning and Health; WHO: Geneva, Switzerland, 2019; Available online: https://www.who.int/news-room/fact-sheets/detail/lead-poisoning-and-health (accessed on 28 April 2021).
- World Health Organization (WHO). Mercury and Health; WHO: Geneva, Switzerland, 2017; Available online: https://www.who.int/news-room/fact-sheets/detail/mercury-and-health (accessed on 28 April 2021).
- Aloizou, A.M.; Siokas, V.; Vogiatzi, C.; Peristeri, E.; Docea, A.O.; Petrakis, D.; Provatas, A.; Folia, V.; Chalkia, C.; Vinceti, M.; et al. Pesticides, cognitive functions and dementia: A review. Toxicol. Lett. 2020, 326, 31–51. [Google Scholar] [CrossRef]
- Gunnarsson, L.G.; Bodin, L. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses. Int. J. Environ. Res. Public Health 2019, 16, 337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yan, D.; Zhang, Y.; Liu, L.; Yan, H. Pesticide exposure and risk of Alzheimer’s disease: A systematic review and meta-analysis. Sci. Rep. 2016, 6, 32222. [Google Scholar] [CrossRef] [Green Version]
- Killin, L.O.; Starr, J.M.; Shiue, I.J.; Russ, T.C. Environmental risk factors for dementia: A systematic review. BMC Geriatr. 2016, 16, 175. [Google Scholar] [CrossRef] [Green Version]
- Olayinka, O.; Olayinka, O.O.; Alemu, B.T.; Akpinar-Elci, M.; Grossberg, G.T. Toxic environmental risk factors for alzheimer’s disease: A systematic review. Aging Med. Healthc. 2019, 10, 4–17. [Google Scholar] [CrossRef]
- Krewski, D.; Barakat-Haddad, C.; Donnan, J.; Martino, R.; Pringsheim, T.; Tremlett, H.; van Lieshout, P.; Walsh, S.J.; Birkett, N.J.; Gomes, J.; et al. Determinants of neurological disease: Synthesis of systematic reviews. Neurotoxicology 2017, 61, 266–289. [Google Scholar] [CrossRef] [PubMed]
- Mostafalou, S.; Abdollahi, M. Pesticides: An update of human exposure and toxicity. Arch. Toxicol. 2017, 91, 549–599. [Google Scholar] [CrossRef] [PubMed]
- Santibáῆez, M.; Bolumar, F.; García, A.M. Occupational risk factors in Alzheimer’s disease: A review assessing the quality of published epidemiological studies. Occup. Environ. Med. 2007, 64, 723–732. [Google Scholar] [CrossRef] [Green Version]
- Xu, L.; Zhang, W.; Liu, X.; Zhang, C.; Wang, P.; Zhao, X. Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer’s Disease: A Quantitative Meta-Analysis and Systematic Review. J. Alzheimers Dis. JAD 2018, 62, 361–372. [Google Scholar] [CrossRef] [Green Version]
- Cicero, C.E.; Mostile, G.; Vasta, R.; Rapisarda, V.; Signorelli, S.S.; Ferrante, M.; Zappia, M.; Nicoletti, A. Metals and neurodegenerative diseases. A systematic review. Environ. Res. 2017, 159, 82–94. [Google Scholar] [CrossRef] [PubMed]
- Gong, G.; O’Bryant, S.E. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2010, 24, 311–316. [Google Scholar] [CrossRef] [PubMed]
- Mutter, J.; Curth, A.; Naumann, J.; Deth, R.; Walach, H. Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J. Alzheimers Dis. JAD 2010, 22, 357–374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sharma, S.; Wakode, S.; Sharma, A.; Nair, N.; Dhobi, M.; Wani, M.A.; Pottoo, F.H. Effect of environmental toxicants on neuronal functions. Environ. Sci. Pollut. Res. 2020, 27, 44906–44921. [Google Scholar] [CrossRef]
- Wang, X.; Huang, X.; Zhou, L.; Chen, J.; Zhang, X.; Xu, K.; Huang, Z.; He, M.; Shen, M.; Chen, X.; et al. Association of arsenic exposure and cognitive impairment: A population-based cross-sectional study in China. Neurotoxicology 2021, 82, 100–107. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.W.; Liou, S.H.; Hsueh, Y.M.; Lyu, W.S.; Liu, C.S.; Liu, H.J.; Chung, M.C.; Hung, P.H.; Chung, C.J. Risk of Alzheimer’s disease with metal concentrations in whole blood and urine: A case-control study using propensity score matching. Toxicol. Appl. Pharmacol. 2018, 356, 8–14. [Google Scholar] [CrossRef] [PubMed]
- Li, X.L.; Zhan, R.Q.; Zheng, W.; Jiang, H.; Zhang, D.F.; Shen, X.L. Positive association between soil arsenic concentration and mortality from alzheimer’s disease in mainland China. J. Trace Elem. Med. Biol. 2020, 59, 126452. [Google Scholar] [CrossRef] [PubMed]
- Siblerud, R.; Mutter, J.; Moore, E.; Naumann, J.; Walach, H. A hypothesis and evidence that mercury may be an etiological factor in Alzheimer’s Disease. Int. J. Environ. Res. Public Health 2019, 16, 5152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Azar, J.; Yousef, M.H.; El-Fawal, H.; Abdelnaser, A. Mercury and Alzheimer’s disease: A look at the links and evidence. Metab. Brain Dis. 2021, 36, 361–374. [Google Scholar] [CrossRef]
- Bakulski, K.M.; Seo, Y.A.; Hickman, R.C.; Brandt, D.; Vadari, H.S.; Hu, H.; Park, S.K. Heavy metals exposure and Alzheimer’s Disease and related dementias. J. Alzheimers Dis. JAD 2020, 76, 1215–1242. [Google Scholar] [CrossRef] [PubMed]
- Loef, M.; Mendoza, L.F.; Walach, H. Lead (Pb) and the risk of Alzheimer’s disease or cognitive decline: A systematic review. Toxin Rev. 2011, 30, 103–114. [Google Scholar] [CrossRef]
- Tyas, S.L.; Manfreda, J.; Strain, L.A.; Montgomery, P.R. Risk factors for Alzheimer’s disease: A population-based, longitudinal study in Manitoba, Canada. Int. J. Epidemiol. 2001, 30, 590–597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hayden, K.M.; Norton, M.C.; Darcey, D.; Ostbye, T.; Zandi, P.P.; Breitner, J.C.; Welsh-Bohmer, K.A.; Cache County Study Investigators. Occupational exposure to pesticides increases the risk of incident AD: The Cache County study. Neurology 2010, 74, 1524–1530. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Richardson, J.R.; Roy, A.; Shalat, S.L.; von Stein, R.T.; Hossain, M.M.; Buckley, B.; Gearing, M.; Levey, A.I.; German, D.C. Elevated serum pesticide levels and risk for Alzheimer disease. JAMA Neurol. 2014, 71, 284–290. [Google Scholar] [CrossRef] [PubMed]
- Canadian Study of Health and Aging. The Canadian Study of Health and Aging: Risk factors for Alzheimer’s disease in Canada. Neurology 1994, 44, 2073–2080. [Google Scholar] [CrossRef] [PubMed]
- Parrón, T.; Requena, M.; Hernández, A.F.; Alarcón, R. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol. Appl. Pharmacol. 2011, 256, 379–385. [Google Scholar] [CrossRef] [PubMed]
- Baldi, I.; Lebailly, P.; Mohammed-Brahim, B.; Letenneur, L.; Dartigues, J.F.; Brochard, P. Neurodegenerative diseases and exposure to pesticides in the elderly. Am. J. Epidemiol. 2003, 157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gun, R.T.; Korten, A.E.; Jorm, A.F.; Henderson, A.S.; Broe, G.A.; Creasey, H.; McCusker, E.; Mylvaganam, A. Occupational risk factors for Alzheimer disease: A case-control study. Alzheimer Dis. Assoc. Disord. 1997, 11, 21–27. [Google Scholar] [CrossRef] [PubMed]
- European Commission. Health and Food Safety-Plants-Pesticides Explained; European Commission: Brussels, Belgium, 2021; Available online: https://ec.europa.eu/assets/sante/food/plants/pesticides/lop/index.html (accessed on 5 May 2021).
- European Commission. Report from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions—Findings of the Fitness Check of the Most Relevant Chemicals Legislation (Excluding REACH) and Identified Challenges, Gaps and Weaknesses; European Commission: Brussels, Belgium, 2019; Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52019DC0264&from=EN (accessed on 20 May 2021).
- Grant, M.J.; Booth, A. A typology of reviews: An analysis of 14 review types and associated methodologies. Health Info. Libr. J. 2009, 26, 91–108. [Google Scholar] [CrossRef] [PubMed]
Substance | Measurement Matrix |
---|---|
As [10] | Urine, blood, sometimes measured in hair, nails |
Cd [10,17,18,19] | Urine: long-term accumulation and exposure, blood: short-term exposure, sometimes measured in hair, nails, saliva, breast milk, placenta, or meconium |
Pb [10,18,20,21] | Blood: recent exposure, bone: long-term exposure, urine: long-term occupational exposure, sometimes measured in hair, nails, saliva, breast milk, placenta, or meconium |
Hg [10,18] | Urine, blood, hair, nails, sometimes measured in breast milk or meconium |
Pesticides [10,18] | Urine: short-term exposure, blood: body burden of persistent organochlorine pesticides, sometimes measured in hair: long-term exposure, or in breast milk, meconium, or placenta |
Study: | Included Countries: | Study Design: | Sample: | Chemical: | Exposure Assessment: | Outcome(s): | Results and Main Conclusions: | Summary *: |
---|---|---|---|---|---|---|---|---|
Aloizou et al., 2020 [30] | US, UK, Ecuador, South Africa, Costa Rica, Brazil, Egypt, Spain, Iran, France, India, Sweden, China, Chile, Gulf, Netherlands, Greece, Canada, Australia, Taiwan | Review | N of studies: 30 human studies (and 15 animal studies) Setting: cross-sectional, longitudinal, case-control, cohort, case cohort, and ecological studies Target group: occupational | pesticides | questionnaire: occupational and non-occupational, environmental and self-reported-pesticides exposures, and place of residence serum: cholinesterase, acetylcholinesterase, and OC pesticides levels plasma: butyrylcholinesterase (BuChE) and red blood cell acetylcholinesterase (AChE) activity and concentrations of 3 OC pesticides urine: TCP levels, DEP, DETP, DAP metabolites, and TCPy | cognitive functions, dementia, and AD | An overall indication from epidemiologic evidence supported an association between exposure to neurotoxic pesticides and cognitive dysfunction, dementia, and AD. | ⇧ |
Gunnarsson and Bodin, 2019 [31] | Not specified | Systematic literature review and meta-analyses | N of studies: 31 studies on pesticides (4 on AD) and 14 studies on metals (3 on AD) Setting: cohort or case-control studies Target group: occupational | pesticides | Job Exposure Matrix (JEM), self-reported exposure (questionnaire/interviews), DDE concentration in serum, AD diagnosis, severity of AD measured by the Mini-Mental State Examination (MMSE) score, and interaction with apolipoprotein E (APOE4) status | AD | The relative risk (RR) for AD and pesticides was 1.50 (95% confidence interval (CI) 0.98–2.29). Exposure to pesticides increased the risk of AD by at least 50%. | ⇧ |
Yan et al., 2016 [32] | Canada, France, US, Australia | Systematic review and meta-analysis | N of studies: 7 Setting: 3 cohort and 4 case-control studies Target group: occupational, AD patients, and healthy controls | pesticides | prospectively, self-report ever/never occupational exposure, retrospectively, proxy reports job history, risk factor information, and code into JEM | AD | A positive association between pesticide exposure and AD was detected: odds ratio (OR) = 1.34 (95% CI 1.08–1.67). The summary ORs from the crude and adjusted effect size studies were 1.14 (0.94–1.38, N = 7) and 1.37 (1.09–1.71, N = 5), respectively. All subgroup analyses showed that pesticide exposure was associated with an increased risk of AD but only half of them with statistical significance. A significantly increased risk detected in cohort studies: OR = 1.37 (1.08–1.75) but not in case-control studies: OR = 1.24 (0.78–1.97). The OR of the self-reported group was 1.37 (1.08–1.75), and the OR of the proxy-reported group was 1.24 (0.78–1.97) when stratified according to method used to access exposure. | ⇧ ⇔ |
Killin et al., 2016 [33] | Canada, US, France, Netherlands, UK | Systematic review | N of studies: 60 (10 on pesticides, 2 on As, and 2 on Pb) Setting: 6 cohort, 2 cross-sectional, 2 review studies on pesticides, 2 cross-sectional studies on As, 1 cross-sectional, and 1 review study on Pb Target group: occupational, environmental, and regional | pesticides, Pb, and As | self-reported risk factor and exposure to pesticides by questionnaire, exposure to pesticides from residential history and census data, cumulative exposure to pesticides based on job history, comparison of annual aveage-adjusted mortality rates between two different locations (As), principal components analysis, and AD cases identified from a registry (Pb) | dementia, and AD | Quality of overall evidence regarding defoliants/fumigants was weak but regarding pesticides/fertilizers/herbicides/insecticides strong. Among the different chemicals investigated, the strongest evidence was found for pesticide exposure but findings were heterogenous. Evidence of associations between occupational exposure, Pb, As and dementia was rather weak. | ⇔ for pesticides ⇩ for Pb and As |
Olayinka et al., 2019 [34] | Sweden, UK, Canada, France, US, Australia, Turkey, Denmark, Taiwan, Finland, Japan | Systematic review | N of studies: 29 (6 on pesticides, 2 on Pb, and 1 on Hg) Setting: 11 cohort and 18 case-control studies Target group: occupational and environmental | pesticides and metals (Pb, Hg) | occupational and environmental exposure | AD | Significant evidence was detected of the association between pesticide exposure and AD, depending on the group of the pesticides; occupational exposure to OP pesticides, fumigants and defoliants was more significant than occupational exposure to pesticides such as herbicides and insecticides in relation to AD risk. Due to the low number of studies, the effect of Pb and Hg on AD risk was difficult to estimate. | ⇧ ⇩ for pesticides ⇔ for Pb and Hg |
Krewski et al., 2017 [35] | Not specified | Synthesis of systematic reviews | Studies on the risk factors associated with the onset and progression of 14 neurological conditions, including AD | pesticides | - | AD | Exposure to pesticides was associated with AD with sufficient evidence. | ⇧ |
Mostafalou and Abdollahi, 2017 [36] | Not specified | Systematic review | N of studies: 448 (6 on AD) Setting: 2 case-control, 3 cohort, and 1 ecological studies Target group: occupational and environmental | pesticides | questionnaire, geographic information system (GIS), and level of pesticides in serum | AD | In cohort studies there were 1.4- and 2.4-times higher risk of AD in people occupationally exposed to any pesticides and 1.5 increased risk of AD with exposure to OP and OC compounds based on the longitudinal and prospective analysis of exposures. | ⇧ |
Santibáῆez et al., 2007 [37] | Canada, France, US, England and Wales, Australia | Systematic review | N of studies: 24 (6 on pesticides and 6 on Pb) Setting: 21 case-control and 3 cohort studies Target group: occupational | pesticides and Pb | occupational exposure | AD | Increased and statistically significant associations between AD and pesticide exposure were observed in studies of greater quality and prospective design. No evidence was detected of association for Pb. | ⇧ for pesticides ⇩ for Pb |
Xu et al., 2018 [38] | Korea, Australia, Spain, Italy, China, Sweden | Quantitative meta-analysis and systematic review | N of studies: 42 (7 on Hg, 8 on Cd, and 10 on Pb) Setting: case-control studies Target group: AD patients and healthy controls | Cd, Hg, and Pb | levels of toxic metals assessed from the circulation (blood, serum/plasma) | AD | According to the meta-analysis significantly elevated circulatory levels of Hg: pooled standardized mean difference (SMD) = 0.55 (95% CI 0.15–0.95, p = 0.0073) and Cd (SMD = 0.62, 0.12–1.11, p = 0.0144) were detected in AD patients compared to controls. Regarding Pb, reduced circulatory levels detected in AD patients in comparison to controls (SMD = −0.23, −0.38 to −0.07, p = 0.0043). Elevated Cd- and Hg-levels in the circulation, especially in serum, may contribute to the progression of AD. | ⇧ for Hg and Cd ⇩for Pb |
Cicero et al., 2017 [39] | Not specified | Systematic review | N of studies: - Setting: case-control studies Target group: occupational, AD patients, and healthy controls | Pb, Hg, Cd, and As | blood/serum/plasma, cerebrospinal fluid (CSF), nail, and hair | AD, dementia, and cognitive functions | An inverse relation between Hg excretion and cognitive functions in exposed workers was detected. In four case-control studies higher blood Hg levels in AD patients compared to controls. However, in the other studies, lower concentrations of Hg (one study) or no difference (four studies). No differences in the CSF Hg concentration (two studies). Nail-Hg concentrations significantly lower in AD patients (two studies), and inconsistent findings in the hair-Hg examination (two studies). Data was inconclusive on Cd, As, and Pb. | ⇧ ⇩ ⇔ |
Gong and O’Bryant, 2010 [40] | Not specified | Review | Both animal and epidemiological studies | As | Not specified | AD | As-exposure hypothesis was supported by a simple mechanism for AD development and progression in certain AD patients. As exposure is associated with amyloid, vascular, and inflammatory hypotheses of AD. | ⇧ |
Mutter et al., 2010 [41] | Not specified | Systematic review | N of studies: 88 (incl. 8 animal studies) Setting: mainly case-control and comparative cohort studies, also cross-sectional studies Target group: occupational | Hg | brain tissue, blood, urine, hair, nails, and CSF | AD | Significant memory deficits in individuals exposed to inorganic Hg was found in 32 out of 40 studies. In some autopsy studies elevated Hg-levels detected in brain tissues of AD patients. Measurements of Hg-levels in blood, urine, hair, nails, and CSF were discrepant. Inorganic Hg may contribute to the development of AD, increase the pathological influence of other metals, and promote neurodegenerative disorders via disruption of redox regulation. The influence of inorganic Hg on the nervous system was weaker in epidemiological studies compared to animal and in vitro-studies. | ⇧ ⇔ |
Sharma et al., 2020 [42] | Not specified | Review | The available data for human neurotoxicity due to toxic chemicals was collected | Pb, Hg, Cd, As, and pesticides | - | AD | Neurotoxic metals such as Pb, Hg, Cd, and As as well as some pesticides have been associated with AD because of their ability to produce senile/amyloid plaques and neurofibrillary tangles (NFTs)-the features behind the neuronal dysfunctions such as AD. | ⇧ |
Wang et al., 2021 [43] | China | Cross-sectional study | N: 1556 adults (802 males and 754 females, an average age of 57.0 +/− 11.5 years). 321 (20.6%) participants in the cognitive-impaired (CI)-group and 1235 (79.4%) participants in the cognitive-normal (CN)-group. | As | cognitive function measured by Chinese version of MMSE, internal-As exposure measured by hair As-concentrations (HAs), and external-As exposure measured by the distance between the participant‘s location of residence and the Realgar Plant | cognitive impairment | The CI-group had a significantly lower MMSE score compared to the CN-group (16.6 +/− 5.47 vs. 26.3 +/− 2.81, p < 0.05). In the CI-group much higher HAs than in the CN-group with a statistically significant difference (0.27, 0.14–0.56 mg/kg vs. 0.20, 0.10–0.41 mg/kg, p < 0.05). The prevalence of arsenicosis (arsenic poisoning) was significantly higher in the CI-group compared to the CN-group (64.5% vs. 45.3%, p ˂ 0.05). A negative correlation between hair-As concentrations and MMSE scores was detected (correlation coefficient (r) = −0.151, p < 0.001). Arsenicosis was a risk factor for cognitive impairment (OR = 1.84, p ˂ 0.05). | ⇧ |
Yang et al., 2018 [44] | Taiwan | Case-control study | N: 434 adults (170 AD patients and 264 controls, age ≥ 50 years, an average age of 73.65, standard deviation (SD) 8.46). A propensity-score-matched population of 82 AD patients and 82 controls. | Cd, Pb, Hg, and As | AD patients: clinical neuropsychological examination and cognitive-function assessments incl. MMSE and clinical dementia-rating scale. Blood levels of Cd, Pb, and Hg and urine levels of As levels. | AD risk | The AD risk of study participants with high urinary inorganic As (InAs%) or low dimethylarsinic acid (DMA%) was significantly increased (p ˂ 0.05), similar findings in the propensity-score-matched population. People with high median level of InAs% or/and a low median level of DMA% had approximately two- to threefold significant AD risk. Cd, Pb, and Hg were not associated with AD risk. | ⇧ for As ⇩ for Cd, Pb, and Hg |
Li et al., 2020 [45] | China | Ecological study | 22 provinces and 3 municipal districts in mainland China | As, Pb, Cd, and Hg | As- concentrations in soil in 1990 obtained from the China State Environmental Protection Bureau and data on annual mortality of AD from 1991 to 2000 obtained from the National Death Cause Surveillance Database of China | As concentrations in soil and AD mortality | AD mortality was increased by soil As concentration, the Spearman correlation coefficient between As concentration and AD mortality was 0.552 (p = 0.004), 0.616 (p = 0.001), and 0.622 (p = 0.001) in the A soil As (eluvial horizon), the C soil As (parent material horizon), and the total soil As (A soil As + C soil As), respectively. Evidence was found of a possible causal association between As exposure and the death risk from AD. No association was detected between Pb, Cd, and Hg soil concentrations and AD mortality. | ⇧ for As ⇩ for Pb, Cd, and Hg |
Siblerud et al., 2019 [46] | Not specified | Hypothesis | - | Hg | 70 factors were identified as occurring in AD; factors were investigated in relation to Hg exposure | AD | All 70 factors associated with AD were examined and all of them could be explained by Hg toxicity. The hallmark changes of AD: plaques, beta amyloid protein, neurofibrillary tangles, phosphorylated tau protein, and loss of memory could all be changes caused by Hg. Neurotransmitters such as acetylcholine, serotonin, dopamine, glutamate, and norepinephrine are inhibited in AD patients, and same inhibition occurs in Hg toxicity. It was strongly suggested that Hg can cause AD. | ⇧ |
Azar et al., 2021 [47] | Not specified | Review | Both animal and epidemiological studies | Hg | - | AD | Hg was involved in the process of amyloid beta deposition and tau tangles formation, which contributed to the development of AD. | ⇧ |
Bakulski et al., 2020 [48] | Not specified | Review | Both experimental and epidemiological studies, partly in occupational settings | Pb and Cd | Pb in blood or in bone (tibia or patella) and Cd in brain tissues (postmortem studies), in circulation concentrations (whole blood, serum, or plasma), or in urine | AD, dementia, and cognitive decline | Pb exposure was associated with lower cognitive status and longitudinal declines in cognition in older adults. Cd may be associated with decreased cognitive function and clinical AD specifically in human aging studies. The pathophysiologic link between environmental Cd exposure and AD was limited due to the uncertainty in Cd transport to the brain. | ⇧ for Pb ⇔ for Cd |
Loef et al., 2011 [49] | Not specified | Systematic review | N of studies: - Setting: both animal and epidemiological studies, human studies: longitudinal cohort, cross-sectional, and case-control studies, as well as case-report and post-mortem analysis Target group: e.g., occupational and non-occupational cohorts, AD patients, and healthy subjects | Pb | Pb in blood, bone (tibia, patella, or calcaneus), CSF, dentate gyrus, temporal cortex, or in protein fraction from cortical gray and subcortical white matter | cognitive decline, AD, and dementia | Pb had a potential role in the development of AD, and was a risk factor for AD. An effect of long-term Pb exposure on cognitive decline in elderly subject was suggested. A scarcity of conclusive studies including patients with validated AD diagnoses was detected. | ⇧ |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Elonheimo, H.M.; Andersen, H.R.; Katsonouri, A.; Tolonen, H. Environmental Substances Associated with Alzheimer’s Disease—A Scoping Review. Int. J. Environ. Res. Public Health 2021, 18, 11839. https://doi.org/10.3390/ijerph182211839
Elonheimo HM, Andersen HR, Katsonouri A, Tolonen H. Environmental Substances Associated with Alzheimer’s Disease—A Scoping Review. International Journal of Environmental Research and Public Health. 2021; 18(22):11839. https://doi.org/10.3390/ijerph182211839
Chicago/Turabian StyleElonheimo, Hanna Maria, Helle Raun Andersen, Andromachi Katsonouri, and Hanna Tolonen. 2021. "Environmental Substances Associated with Alzheimer’s Disease—A Scoping Review" International Journal of Environmental Research and Public Health 18, no. 22: 11839. https://doi.org/10.3390/ijerph182211839